|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5070192A
(en)
|
1988-03-23 |
1991-12-03 |
The Johns Hopkins University |
Cloned human topoisomerase i: cdna expression, and use for autoantibody detection
|
|
US5154924A
(en)
*
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6497872B1
(en)
|
1991-07-08 |
2002-12-24 |
Neurospheres Holdings Ltd. |
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
|
FR2686087A1
(fr)
|
1992-01-13 |
1993-07-16 |
Inst Nat Sante Rech Med |
Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications.
|
|
US5639856A
(en)
|
1993-09-13 |
1997-06-17 |
The Regents Of The University Of California |
Semaphorin gene family
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6576754B2
(en)
|
1995-11-09 |
2003-06-10 |
Dana-Farber Cancer Institute |
CD100 antigen and uses therefor
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
DE69829891T2
(de)
|
1997-04-07 |
2005-10-06 |
Genentech, Inc., South San Francisco |
Anti-VEGF Antikörper
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
EP0973916A1
(en)
|
1997-04-11 |
2000-01-26 |
Dendreon Corporation |
Composition and method for inducing an immune response against tumour-related antigens
|
|
EP0892047A3
(de)
|
1997-07-09 |
2000-03-08 |
Hoechst Marion Roussel Deutschland GmbH |
Humanes und murines Semaphorin L
|
|
US5968829A
(en)
|
1997-09-05 |
1999-10-19 |
Cytotherapeutics, Inc. |
Human CNS neural stem cells
|
|
US6638501B1
(en)
|
1997-09-29 |
2003-10-28 |
Neurospheres Holdings Ltd. |
Use of multipotent neural stem cell progeny to augment non-neural tissues
|
|
US5958767A
(en)
|
1998-08-14 |
1999-09-28 |
The Children's Medical Center Corp. |
Engraftable human neural stem cells
|
|
ATE407206T1
(de)
|
1998-11-10 |
2008-09-15 |
Univ Rochester |
Methoden zu herstellung von genbanken
|
|
JP3787473B2
(ja)
|
1999-11-30 |
2006-06-21 |
独立行政法人科学技術振興機構 |
セマフォリン受容体
|
|
US6635742B1
(en)
|
2000-01-25 |
2003-10-21 |
Nuvelo, Inc. |
Antibodies specific for semaphorin-like polypeptides
|
|
AU2913801A
(en)
|
1999-12-23 |
2001-07-03 |
Cornell Research Foundation Inc. |
A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells
|
|
IL159177A0
(en)
|
2001-06-20 |
2004-06-01 |
Prochon Biotech Ltd |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
EP1365018A1
(en)
|
2002-05-23 |
2003-11-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
CD100 semaphorin in myelination
|
|
CA2487932A1
(en)
|
2002-05-30 |
2003-12-11 |
Macrogenics, Inc. |
Cd16a binding proteins and use for the treatment of immune disorders
|
|
EP1442749A1
(en)
*
|
2003-01-31 |
2004-08-04 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system
|
|
RS20150135A1
(sr)
|
2003-05-30 |
2015-08-31 |
Genentech Inc. |
Tretman sa anti-vegf antitelima
|
|
CN1922208A
(zh)
|
2003-12-11 |
2007-02-28 |
健泰科生物技术公司 |
用于抑制c－met二聚化及活化的方法和组合物
|
|
JP2007522118A
(ja)
*
|
2004-01-30 |
2007-08-09 |
ペプリン バイオリピッズ ピーティーワイ エルティーディー |
治療用分子および担体分子
|
|
CN101072880A
(zh)
*
|
2004-07-01 |
2007-11-14 |
VIRxSYS股份有限公司 |
载体包装细胞系
|
|
ME01803B
(me)
|
2004-08-05 |
2010-12-31 |
Genentech Inc |
Humanizovani anti-cmet antagonisti
|
|
US20060147449A1
(en)
|
2004-11-15 |
2006-07-06 |
Brass Lawrence F |
Method of using CD100 (or Sema4D) to mediate platelet activation and inflammatory responses
|
|
CA2603780A1
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics, Inc. |
Sema4d in cancer diagnosis, detection and treatment
|
|
JP2007308465A
(ja)
|
2006-05-15 |
2007-11-29 |
Boehringer Ingelheim Internatl Gmbh |
炎症性疾患、自己免疫疾患又は骨吸収異常の治療方法
|
|
WO2008100995A1
(en)
|
2007-02-14 |
2008-08-21 |
Vaccinex, Inc. |
Humanized anti-cd100 antibodies
|
|
US20090181035A1
(en)
|
2008-01-10 |
2009-07-16 |
Genentech, Inc. |
Plexind1 agonists and their use
|
|
US9221895B2
(en)
*
|
2009-03-13 |
2015-12-29 |
The Trustees Of The University Of Pennsylvania |
OX40/TRAIL fusion proteins
|
|
EP2427212B1
(en)
|
2009-05-08 |
2017-08-23 |
Vaccinex, Inc. |
Anti-cd100 antibodies and methods for using the same
|
|
AU2010248761B2
(en)
|
2009-05-15 |
2016-02-11 |
Irx Therapeutics, Inc. |
Vaccine immunotherapy
|
|
CA2802376A1
(en)
|
2010-06-14 |
2011-12-22 |
Vaccinex, Inc. |
Anti-vegf antibodies and uses thereof
|
|
EP2711023B1
(en)
|
2011-05-13 |
2017-07-12 |
National University Corporation Tokyo Medical and Dental University |
Osteogenesis promoter
|
|
EA029023B1
(ru)
|
2011-10-11 |
2018-01-31 |
Вэксинекс, Инк. |
Применение молекул, связывающих семафорин-4d, для модуляции проницаемости гематоэнцефалического барьера
|
|
US8790652B2
(en)
|
2011-12-06 |
2014-07-29 |
Vaccinex, Inc. |
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
|
|
US9090709B2
(en)
|
2012-03-28 |
2015-07-28 |
Vaccinex, Inc. |
Anti-SEMA4D antibodies and epitopes
|
|
US9708601B2
(en)
|
2012-04-26 |
2017-07-18 |
Vaccinex, Inc. |
Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus
|
|
US10494440B2
(en)
|
2012-05-11 |
2019-12-03 |
Vaccinex, Inc. |
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
|
|
US9243068B2
(en)
|
2013-06-25 |
2016-01-26 |
Vaccinex, Inc. |
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
|
|
NZ630881A
(en)
|
2013-10-10 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treatment of atherosclerosis
|
|
NZ630892A
(en)
|
2013-10-21 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
|
|
KR102533921B1
(ko)
*
|
2017-02-22 |
2023-05-17 |
백시넥스 인코포레이티드 |
신경변성 또는 신경염증성 질환에서의 신경교세포 활성화의 조기 검출
|